NCT03322891 is a NA clinical trial of Educational Supplement in Prostate Cancer, sponsored by Emory University.

Who is sponsoring NCT03322891?

NCT03322891 is sponsored by Emory University.

What drugs are being tested in NCT03322891?

Interventions in NCT03322891: Educational Supplement, Standard Practice Education.

What condition does NCT03322891 study?

NCT03322891 studies Prostate Cancer.

Is NCT03322891 still recruiting?

NCT03322891 is currently recruiting now. Last updated 29 January 2026.

Last reviewed 2026-01-29 · How we verify

NCT03322891

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Health Literacy in African-American Prostate Cancer Patients

Recruiting now NA Last updated 29 January 2026

What this trial tests

NA trial testing Educational Supplement in Prostate Cancer in 210 participants. Currently enrolling.

Timeline

21 July 2016

Primary endpoint
31 March 2027

31 March 2027

Quick facts

Lead sponsor	Emory University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	210
Start date	21 July 2016
Primary completion	31 March 2027
Estimated completion	31 March 2027
Sites	4 locations across United States

Drugs / interventions tested

Educational Supplement
Standard Practice Education

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →

Sponsor

Emory University

Who can join

Adults 25 to 100, male only, with Prostate Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Investigators propose an observational interview study to explore how patients understand treatment conversations with their physicians within the framework of health literacy. The study team will test whether patients' understanding of treatment options and side effects can be improved when patients receive a low literacy educational supplement after meeting with their urologist. Investigators will interview a group of newly diagnosed, early stage, African American prostate cancer patients.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.
Dovey ZS, Nair SS, Chakravarty D, Tewari AK. · · 2021 · cited 18× · PMID 33599076 · DOI 10.1002/cnr2.1340

Verify or expand the search:

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other Emory University trials

Trials by the same sponsor.

NCT06143345 — HIIT in Isolated IFG: A Proof-of-Concept Study · NA · withdrawn
NCT07189819 — Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait · NA · not yet recruiting
NCT06451055 — Low-calorie Diet in Isolated Impaired Fasting Glucose · NA · not yet recruiting
NCT07405476 — Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I · Phase 2 · recruiting
NCT06708351 — Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03322891 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Emory University
Last refreshed: 29 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03322891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing